We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Flywire
FLYW
$2.13B
| $32.3M | 0.52% |
1,056,270
+675,455
| +177% | +$19.2M |
|
52
HubSpot
HUBS
$12.7B
| $32.1M | 0.52% |
+67,602
| New | +$32.8M |
|
53
Microchip Technology
MCHP
$43.7B
| $31.9M | 0.52% |
424,200
-168,700
| -28% | -$12.7M |
|
54
Simply Good Foods
SMPL
$1.01B
| $30.9M | 0.5% |
815,306
+203,679
| +33% | +$7.6M |
|
55
Ciena
CIEN
$58.6B
| $30.8M | 0.5% |
+507,787
| New | +$33.2M |
|
56
Semtech
SMTC
$12.1B
| $30.6M | 0.5% |
441,477
+223,030
| +102% | +$16M |
|
57
CACI
CACI
$11.5B
| $30.3M | 0.49% |
100,606
+10,275
| +11% | +$2.84M |
|
58
Adobe
ADBE
$102B
| $29.9M | 0.49% |
+65,680
| New | +$31.6M |
|
|
CTXS
59
DELISTED
Citrix Systems Inc
CTXS
| $29.6M | 0.48% |
+293,602
| New | +$29.7M |
|
60
ServiceNow
NOW
$120B
| $28.9M | 0.47% |
259,630
-192,835
| -43% | -$21.6M |
|
61
Bristol-Myers Squibb
BMY
$135B
| $28.9M | 0.47% |
395,570
| – | – |
|
62
First Horizon
FHN
$12.4B
| $28.8M | 0.47% |
+1,227,600
| New | +$24.5M |
|
63
Huntington Ingalls Industries
HII
$12.8B
| $28.4M | 0.46% |
+142,362
| New | +$27.8M |
|
64
Edgewell Personal Care
EPC
$1.29B
| $27.4M | 0.45% |
748,258
+171,605
| +30% | +$7M |
|
65
Jazz Pharmaceuticals
JAZZ
$16.3B
| $27.2M | 0.44% |
+175,043
| New | +$25.4M |
|
|
ATVI
66
DELISTED
Activision Blizzard
ATVI
| $26.8M | 0.44% |
+334,800
| New | +$26.1M |
|
67
nVent Electric
NVT
$26.4B
| $26.6M | 0.43% |
765,232
+305,318
| +66% | +$10.7M |
|
68
Gilead Sciences
GILD
$163B
| $25.1M | 0.41% |
421,707
-228,381
| -35% | -$14.6M |
|
69
Howmet Aerospace
HWM
$116B
| $24.7M | 0.4% |
687,269
+60,535
| +10% | +$2.07M |
|
70
Coty
COTY
$2.55B
| $24.6M | 0.4% |
2,740,082
-786,590
| -22% | -$7.01M |
|
71
Snap
SNAP
$9.56B
| $24.5M | 0.4% |
+680,669
| New | +$24.6M |
|
72
Neurocrine Biosciences
NBIX
$17B
| $24.3M | 0.4% |
259,635
+131,992
| +103% | +$11.2M |
|
|
WBT
73
DELISTED
Welbilt, Inc.
WBT
| $24.3M | 0.39% |
1,023,657
+474,956
| +87% | +$11.3M |
|
74
Synopsys
SNPS
$76.9B
| $23.8M | 0.39% |
71,396
+33,187
| +87% | +$10.4M |
|
75
Bausch Health
BHC
$2.42B
| $23.2M | 0.38% |
1,013,462
+10,944
| +1% | +$268K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.